Entrada Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Entrada Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2022 to Q3 2024.
  • Entrada Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 355 %, a 15.6% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 355 +48 +15.6% Sep 30, 2024
Q2 2024 284 -117 -29.1% Jun 30, 2024
Q1 2024 250 -292 -53.9% Mar 31, 2024
Q4 2023 264 -997 -79.1% Dec 31, 2023
Q3 2023 307 -1.41K -82.1% Sep 30, 2023
Q2 2023 400 -1.6K -80% Jun 30, 2023
Q1 2023 541 Mar 31, 2023
Q4 2022 1.26K Dec 31, 2022
Q3 2022 1.72K Sep 30, 2022
Q2 2022 2K Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.